AI Value Creation in Private Equity: How to Prioritise Use Cases Across Portfolio Companies

Three conversations, one problem.

A managing director of operations transformation at a pan-European private-equity firm wants to scope and prioritise AI opportunities across roughly fifty portfolio companies — pilots, business cases, productivity analysis, an implementation roadmap. An independent investment company with a portfolio of people businesses sees AI as a direct margin lever, because a striking share of operational and knowledge work in its companies is still manual. And a PE-backed SaaS platform wants to move from fragmented AI tool experimentation towards a standardised, AI-native engineering and product-development model, with every initiative connected to measurable business impact.

These look like three different AI problems. They are not. They are three versions of the same value-creation problem — and none of them is primarily about technology.

AI value creation across portfolio companies is not primarily a technology-selection problem. It is a portfolio-management and decision-system problem.

Portfolio companies do not lack AI ideas, and they certainly do not lack AI vendors. What they lack is a reliable way to decide: where AI can create meaningful value, which opportunities to prioritise, which initiatives to stop, what evidence is needed before scaling, what should be standardised at fund level, and whether each validated scope should be built, bought or delivered with a partner.

Why portfolio AI becomes a portfolio-management problem

Inside a single company, an undisciplined AI programme wastes budget. Across a portfolio, the waste compounds.

Every portfolio company generates its own longlist of use cases, described at wildly different levels of detail. One company's "AI opportunity" is a two-line idea from a workshop; another's is a costed business case with a data assessment behind it. When those artefacts reach an investment committee, they cannot be compared — so funding decisions default to enthusiasm, sponsorship and whoever presents best.

Meanwhile, the questions an operating partner actually needs answered are portfolio-management questions. How do we make use cases comparable across companies? How do we distinguish technical possibility from business value? What evidence do we require before scaling anything? How do we move from isolated pilots to a coherent roadmap? What belongs at fund level, and what must remain company-specific?

There is also a structural reason the stakes are higher in a portfolio context. A fund's advantage over a corporate is repeatability: a lesson learned in one company can be redeployed across ten others within the hold period. AI is unusually well suited to that motion — the margin levers in a people business, a SaaS platform and an industrial operator differ in content, but the discipline for finding and validating them is identical. A fund that builds the discipline once amortises it across every company and every future deal. A fund that doesn't runs fifty uncoordinated science projects.

Treat those as fifty separate technology questions and you get fifty separate answers. Treat them as one decision-system question and you get something a fund can actually reuse.

A collection of local pilots is not a value-creation strategy

The default failure mode is well-intentioned: let every company experiment, and see what sticks.

The result is that the fund pays for the same lessons several times. Each pilot answers a local question with local methods. Nothing transfers: no comparable business cases, no shared definition of success, no common kill criteria, no reusable partner ecosystem. Two companies evaluate the same category of vendor in the same quarter without knowing it. A third keeps a politically sponsored pilot alive long after the evidence turned against it, because nobody defined upfront when it would be stopped.

The portfolio accumulates activity. It does not accumulate evidence.

The instinctive correction — centralise everything — fails in the opposite direction. AI value lives inside specific workflows: this claims process, this pricing desk, this customer-onboarding flow. A fund that centralises implementation ends up pushing solutions into companies that do not own them. The craft is knowing which layer to standardise.

What belongs at fund level

Centralise the decision system:

• Opportunity taxonomy — one shared structure for describing AI opportunities, so a use case in logistics and a use case in underwriting can sit in the same portfolio view.
• Prioritisation methodology — the same scoring dimensions everywhere: strategic relevance, business value, technical feasibility, data readiness, process impact, user adoption, risk, speed to evidence, scalability.
• A minimum business-case standard — no initiative enters the portfolio without an owner, a value hypothesis and a KPI.
• Governance and decision cadence — who reviews the portfolio, how often, and with authority to stop things.
• Evidence and reporting standards — a single source of truth for what each initiative has actually proven.
• Pilot and Minimal Viable Agent principles — including kill criteria defined before launch.
• Shared learning — what company A proved, company B should not have to re-prove.
• A reusable partner ecosystem — vetted delivery options, matched to scope types rather than sold company by company.

What must remain local

Everything that touches the actual workflow stays with the company: process redesign, operational ownership, data and systems, solution architecture, user adoption and change management, implementation and delivery. The fund standardises how decisions get made; the company owns what gets done and how it runs. Funds that invert this — loose decision standards, centralised delivery — get the worst of both.

The seven disciplines of portfolio AI value creation

In practice, portfolio AI value creation rests on seven disciplines.

1. Governance. A portfolio decision cadence with teeth: a body that reviews evidence, allocates attention, and stops initiatives. Not a steering committee that admires progress — a mechanism that forces choices.

2. Inside-out use-case structuring. Bring every company's ideas to the same level of detail: the workflow affected, the user, the owner, the value hypothesis. Most "AI strategy" problems dissolve at this step, because half the longlist turns out to be aspirations rather than use cases. This is the discipline of use-case prioritisation and scoping applied portfolio-wide.

3. Business-case-based prioritisation. Score every structured use case on the same dimensions and rank across the portfolio, not within each company. The output is uncomfortable and useful in equal measure: some companies' favourite projects rank far below another company's unglamorous back-office workflow.

4. Kill criteria. Decide before launch what evidence would stop each initiative. Kill criteria are the cheapest governance instrument available: they convert "we should probably stop this" from a political fight into a pre-agreed outcome, and they free budget and leadership attention for what is working.

5. Outside-in synchronisation. Internal teams can only propose what they can see. Peers, adjacent sectors and AI-native firms have already tested approaches your companies have not imagined — and abandoned approaches your companies are about to fund. An outside-in benchmark synchronises the portfolio with that external reality before capital is committed.

6. Minimal Viable Agents. The validation instrument. A Minimal Viable Agent is the smallest working AI-enabled workflow that proves technical feasibility, user adoption and business value end to end — before a larger implementation. It is not a chatbot demo, not a disconnected proof of concept, and not a pilot without success criteria. One MVA on a real workflow with real users produces more decision-grade evidence than a quarter of parallel experimentation.

7. Build, buy or partner decisions. Only after validation does the delivery question become answerable. Build when the capability is strategic and the team exists; buy when a configurable platform covers the validated workflow; partner when specialist speed or expertise is decisive. The decision must be made independently — an implementation vendor asked to define the problem will, quite rationally, define it around what it already sells.

An illustrative 90-day approach

The exact weeks matter less than the sequence; the timeline below is illustrative, and the pace depends on portfolio size and data access.

Days 1–20 — Govern and map. Stand up portfolio governance and the decision cadence. Run strategic-priority interviews with company leadership. Agree the opportunity taxonomy and build the initial longlist.

Days 21–40 — Structure and prioritise. Structure use cases to the common standard. Attach value hypotheses, feasibility and data-readiness assessments. Prioritise across the portfolio and define kill criteria for everything that advances.

Days 41–70 — Validate. Launch Minimal Viable Agents for the selected use cases. Validate with real users, gather evidence against the pre-agreed metrics, and compare delivery options in parallel.

Days 71–90 — Decide and mobilise. Make go, redesign or stop decisions against the kill criteria. Make build, buy or partner decisions per validated scope. Consolidate into a portfolio roadmap, a reusable playbook, and an executive narrative supported by evidence.

What a decision-ready output looks like

At the end, the fund and each participating company should hold, concretely: a prioritised opportunity portfolio; a business owner per use case; a value hypothesis and KPI per use case; technical and data dependencies; adoption implications; kill criteria; an MVA brief for each validated candidate; explicit decision logic; a build, buy or partner recommendation; a portfolio roadmap; a reusable playbook; and a board-level narrative that survives scrutiny because every claim in it traces back to evidence.

If a programme cannot produce that list, it is not a value-creation programme yet. It is exploration — which is fine, as long as nobody prices it as value creation.

Note what is not on the list: a technology recommendation. By the time a platform or model choice matters, the workflow, the evidence and the delivery path are already clear — which is precisely what makes the eventual technology decision fast, comparable and hard for a vendor to distort.

Common failure modes

The recurring ways portfolio AI programmes go wrong, in roughly the order they appear:

• Starting with technology — selecting a platform before the workflow and business requirement are understood.
• Letting every company invent its own methodology — guaranteeing incomparable business cases.
• Centralising implementation too aggressively — fund-level teams delivering solutions no company owns.
• Launching too many pilots — spreading leadership attention until nothing reaches evidence.
• Measuring activity instead of value — counting pilots and workshops rather than validated outcomes.
• Treating data readiness as binary — waiting for perfect data instead of scoping what is good enough for v1.
• Selecting partners before defining scope — inviting the vendor to define the problem around its product.
• Keeping politically sponsored pilots alive — the direct cost of missing kill criteria.
• Failing to redesign the workflow — layering AI onto an unchanged process and wondering why the value never lands.

Each of these is a decision-system failure. None is a technology failure.

The decision system is the asset

The lasting output of a portfolio AI programme is not any single use case. It is the repeatable system: the taxonomy, the prioritisation methodology, the evidence standards, the kill discipline, the validation instrument, the partner ecosystem. Use cases come and go; the system compounds across companies and across deals — it is, in effect, the fund's AI portfolio strategy made operational.

That is also where independence earns its keep. A fund does not need another party with an incentive to recommend a large implementation. It needs the scoping, prioritisation and validation layer to sit with an advisor who earns nothing from the build — so that what gets funded is determined by the business case, and by nothing else.